CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls

BACKGROUND: Neurofilament light chain is a marker of axonal damage and is of interest as a biofluid biomarker for PD. The objective of this study was to investigate whether CSF or serum neurofilament contributes to a combination of CSF biomarkers in defining the optimal biomarker panel for discrimin...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mov Disord
Main Authors: Oosterveld, Linda P., Verberk, Inge M.W., Majbour, Nour K., El‐Agnaf, Omar M., Weinstein, Henry C., Berendse, Henk W., Teunissen, Charlotte E., van de Berg, Wilma D.J.
格式: Artigo
語言:Inglês
出版: John Wiley & Sons, Inc. 2019
主題:
Research Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7027879/
https://ncbi.nlm.nih.gov/pubmed/31737952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27897
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍